股票代码
000661
About
Group introduction
Leading teams
Organizational chart
Enterprise culture
Development strategy
Honor qualification
Investment enterprise
Business
Pharmaceutical industry
Real-estate development
Innovation
News
Investor
Stock information
Company governance
Periodical report
Company announcement
Interactive platform
Talent
Talent concept
Talent recruitment
Talent cultivation
CSR
Concept of responsibility
Public welfare
CN
About
Group introduction
Leading teams
Organizational chart
Enterprise culture
Development strategy
Honor qualification
Investment enterprise
Business
Pharmaceutical industry
Real-estate development
Innovation
News
Investor
Stock information
Company governance
Periodical report
Company announcement
Interactive platform
Talent
Talent concept
Talent recruitment
Talent cultivation
CSR
Concept of responsibility
Public welfare
To stimulate the potential of life so that life blossomed in the hone
Investor
Periodical report
Company announcement
Interactive platform
CN
Stock information
Company governance
Periodical report
Company announcement
Interactive platform
Home
About
Group introduction
Leading teams
Organizational chart
Enterprise culture
Development strategy
Honor qualification
Investment enterprise
Business
Pharmaceutical industry
Real-estate development
Innovation
News
Investor
Stock information
Company governance
Periodical report
Company announcement
Interactive platform
Talent
Talent concept
Talent recruitment
Talent cultivation
CSR
Concept of responsibility
Public welfare
Total
2,226
announcements
关于子公司GenSci142胶囊境内生产药品注册临床试验申请获得批准的公告
2025-11-28
关于控股股东股权结构发生变更的公告
2025-11-21
关于子公司注射用GenSci140境内生产药品注册临床试验申请获批的公告
2025-11-15
关于回购公司股份期限届满暨回购完成的公告
2025-11-15
关于子公司GS3-007a干混悬剂境内生产药品临床试验申请获得批准的公告
2025-11-15
关于子公司注射用GenSci143境外生产药品注册临床试验申请获得批准的公告
2025-11-14
关于子公司吸附无细胞百(二组分)白破联合疫苗(成人及青少年用)临床试验申请获得批准的公告
2025-11-13
关于子公司GenSci134注射液境内生产药品注册临床试验申请获得批准的公告
2025-11-04
关于回购股份进展情况的公告
2025-11-01
关于子公司注射用GenSci143境内生产药品注册临床试验申请获得批准的公告
2025-11-01
关于子公司GenSci134注射液境内生产药品注册临床试验申请获得批准的公告
2025-11-01
2025年三季度报告
2025-10-31
关于子公司GenSci098注射液境内生产药品注册临床试验申请获得批准的公告
2025-10-28
关于子公司GenSci142胶囊国内生产药品注册临床试验申请获得受理的公告
2025-10-22
关于子公司注射用GenSci139境内生产药品临床试验获批的公告
2025-10-21
上一页
1
2
3
4
5
6
下一页